BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 4, 2012
View Archived Issues
Researchers at Allergan prepare new S1P1 receptor ligands
Read More
TiGenix reports on phase I Cx-621 trial
Read More
Tissue Therapies provides update on CE mark application for wound-healing product
Read More
PAION receives government grant for thrombomodulin mutants
Read More
DiscoveryBioMed receives funding to support metabolic diseases drug discovery program
Read More
Safety results presented on new MedImmune immunotherapeutic
Read More
AMG-900 shows promise in first-in-human trial
Read More
Scientists discover cause of Sengers syndrome / News in Context
Read More
Navitoclax administered with bendamustine/rituximab in phase I study
Read More
Dinaciclib is highly active in phase I trial in chronic lymphocytic leukemia
Read More
ImmunoCellular Therapeutics to expand enrollment in ICT-107 trial
Read More
FDA grants priority review for ocriplasmin BLA
Read More
Alla Chem discloses novel antivirals
Read More
New agents for leukemia developed in U.S.
Read More
Novel chemokine receptor antagonists patented by Emory University
Read More
New beta-amyloid inhibitors designed in Japan
Read More
Constellation Pharmaceuticals presents new inhibitors of bromodomain-containing proteins
Read More
Biogen Idec and Isis to collaborate on myotonic dystrophy program
Read More
Ferring Pharmaceuticals gains licensing rights to IBAT inhibitor
Read More
Takeda reports novel anticancer agents
Read More
Drug discovery collaboration begins for postpartum hemorrhage
Read More
BioDelivery Sciences reports on BEMA-buprenorphine/naloxone study
Read More
Leukemia & Lymphoma Society and Celator expand partnership
Read More
CBio discloses planned merger
Read More
FDA accepts NDA for once-weekly contraceptive patch
Read More
EC decides in favor of SkyePharma product's approval for asthma
Read More
Spectrum Pharmaceuticals launches phase II lucanthone trial
Read More